Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides.

Yoshino N, Takeshita R, Kawamura H, Murakami K, Sasaki Y, Sugiyama I, Sadzuka Y, Kagabu M, Sugiyama T, Muraki Y, Sato S.

Scand J Immunol. 2018 Jun 23:e12698. doi: 10.1111/sji.12698. [Epub ahead of print]

PMID:
29935085
2.

[The Collaboration between Clinical Therapy and Academic Study to Benefit Patients].

Sugiyama I, Kudo K, Sadzuka Y.

Yakugaku Zasshi. 2018;138(6):767-772. doi: 10.1248/yakushi.17-00184-4. Review. Japanese.

3.

Dual-effect liposomes with increased antitumor effects against 67-kDa laminin receptor-overexpressing tumor cells.

Sugiyama I, Kaihatsu K, Soma Y, Kato N, Sadzuka Y.

Int J Pharm. 2018 Apr 25;541(1-2):206-213. doi: 10.1016/j.ijpharm.2018.02.041. Epub 2018 Feb 24.

PMID:
29486285
4.

An approach to determining nickel, vanadium and other metal concentrations in crude oil.

Sugiyama I, Williams-Jones AE.

Anal Chim Acta. 2018 Mar 9;1002:18-25. doi: 10.1016/j.aca.2017.11.040. Epub 2017 Nov 23.

PMID:
29306410
5.

Effect of Mixing Time and Storage Condition on Characterization of Heparinoid Admixtures with Corticosteroids.

Sugiyama I, Takahashi N, Sadzuka Y.

Yakugaku Zasshi. 2016;136(10):1391-1400. Japanese.

6.

Effect of Liposomes with Different Double Arms Polyethyleneglycol on Hepatic Metastasis Model Mice and Evaluation Using a Fluorescent Imaging Device.

Sugiyama I, Oikawa H, Masuda T, Sadzuka Y.

Curr Drug Deliv. 2017;14(5):668-675. doi: 10.2174/1567201813666160328113653.

PMID:
27017825
7.

Atomic structures and oxygen dynamics of CeO2 grain boundaries.

Feng B, Sugiyama I, Hojo H, Ohta H, Shibata N, Ikuhara Y.

Sci Rep. 2016 Feb 3;6:20288. doi: 10.1038/srep20288.

8.

Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells.

Sugiyama I, Murayama N, Kuroki A, Kota J, Iwano S, Yamazaki H, Hirota T.

Xenobiotica. 2016 Sep;46(9):765-74. doi: 10.3109/00498254.2015.1118774. Epub 2015 Dec 29.

PMID:
26711482
9.

TTBK2 with EB1/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation.

Watanabe T, Kakeno M, Matsui T, Sugiyama I, Arimura N, Matsuzawa K, Shirahige A, Ishidate F, Nishioka T, Taya S, Hoshino M, Kaibuchi K.

J Cell Biol. 2015 Aug 31;210(5):737-51. doi: 10.1083/jcb.201412075.

10.

Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities.

Sugiyama I, Bouillon T, Yamaguchi M, Suzuki H, Hirota T, Fink M.

Drug Metab Pharmacokinet. 2015 Apr;30(2):160-7. doi: 10.1016/j.dmpk.2014.12.002. Epub 2014 Dec 10.

PMID:
25989891
11.

PAR3 and aPKC regulate Golgi organization through CLASP2 phosphorylation to generate cell polarity.

Matsui T, Watanabe T, Matsuzawa K, Kakeno M, Okumura N, Sugiyama I, Itoh N, Kaibuchi K.

Mol Biol Cell. 2015 Feb 15;26(4):751-61. doi: 10.1091/mbc.E14-09-1382. Epub 2014 Dec 17.

12.

Spatially-resolved mapping of history-dependent coupled electrochemical and electronical behaviors of electroresistive NiO.

Sugiyama I, Kim Y, Jesse S, Strelcov E, Kumar A, Tselev A, Rahani EK, Shenoy VB, Yamamoto T, Shibata N, Ikuhara Y, Kalinin SV.

Sci Rep. 2014 Oct 22;4:6725. doi: 10.1038/srep06725.

13.

Plk1 phosphorylates CLIP-170 and regulates its binding to microtubules for chromosome alignment.

Kakeno M, Matsuzawa K, Matsui T, Akita H, Sugiyama I, Ishidate F, Nakano A, Takashima S, Goto H, Inagaki M, Kaibuchi K, Watanabe T.

Cell Struct Funct. 2014;39(1):45-59. Epub 2014 Jan 22.

14.

[8-year-old complaining of numbness and fatigue of both legs].

Sugiyama I.

No To Hattatsu. 2013 Jul;45(4):265-6. Japanese. No abstract available.

PMID:
23951936
15.
16.

Ferromagnetic dislocations in antiferromagnetic NiO.

Sugiyama I, Shibata N, Wang Z, Kobayashi S, Yamamoto T, Ikuhara Y.

Nat Nanotechnol. 2013 Apr;8(4):266-70. doi: 10.1038/nnano.2013.45. Epub 2013 Mar 24.

PMID:
23524441
17.

Enhanced antitumor activity of different double arms polyethyleneglycol-modified liposomal doxorubicin.

Sugiyama I, Sadzuka Y.

Int J Pharm. 2013 Jan 30;441(1-2):279-84. doi: 10.1016/j.ijpharm.2012.11.032. Epub 2012 Nov 27.

PMID:
23194885
18.

Tiam1 interaction with the PAR complex promotes talin-mediated Rac1 activation during polarized cell migration.

Wang S, Watanabe T, Matsuzawa K, Katsumi A, Kakeno M, Matsui T, Ye F, Sato K, Murase K, Sugiyama I, Kimura K, Mizoguchi A, Ginsberg MH, Collard JG, Kaibuchi K.

J Cell Biol. 2012 Oct 15;199(2):331-45. doi: 10.1083/jcb.201202041.

19.

Beneficial effects by intake of Euphausiacea pacifica on high-fat diet-induced obesity.

Sadzuka Y, Sugiyama I, Miyashita M, Ueda T, Kikuchi S, Oshiro E, Yano A, Yamada H.

Biol Pharm Bull. 2012;35(4):568-72.

20.
21.

[Preparation of liposome using egg yolk].

Sugiyama I, Sadzuka Y.

Yakugaku Zasshi. 2011;131(10):1519-25. Japanese.

22.

Dural cyst at the foramen magnum.

Ohba S, Yoshida K, Sugiyama I, Ikeda E, Kawase T.

Neurol Med Chir (Tokyo). 2011;51(9):671-2.

23.

Numb controls E-cadherin endocytosis through p120 catenin with aPKC.

Sato K, Watanabe T, Wang S, Kakeno M, Matsuzawa K, Matsui T, Yokoi K, Murase K, Sugiyama I, Ozawa M, Kaibuchi K.

Mol Biol Cell. 2011 Sep;22(17):3103-19. doi: 10.1091/mbc.E11-03-0274. Epub 2011 Jul 20.

24.

EB1 promotes microtubule dynamics by recruiting Sentin in Drosophila cells.

Li W, Miki T, Watanabe T, Kakeno M, Sugiyama I, Kaibuchi K, Goshima G.

J Cell Biol. 2011 Jun 13;193(6):973-83. doi: 10.1083/jcb.201101108. Epub 2011 Jun 6.

25.

[Utility and improvement of liposome injections AmBisome for clinical use].

Sugiyama I, Kudo K, Takahashi K, Sadzuka Y.

Yakugaku Zasshi. 2010 Mar;130(3):457-61. Japanese.

26.

Localization of epileptic foci in children with intractable epilepsy secondary to multiple cortical tubers by using synthetic aperture magnetometry kurtosis.

Sugiyama I, Imai K, Yamaguchi Y, Ochi A, Akizuki Y, Go C, Akiyama T, Snead OC 3rd, Rutka JT, Drake JM, Widjaja E, Chuang SH, Cheyne D, Otsubo H.

J Neurosurg Pediatr. 2009 Dec;4(6):515-22. doi: 10.3171/2009.7.PEDS09198.

PMID:
19951036
27.

Serological survey of arthropod-borne viruses among wild boars in Japan.

Sugiyama I, Shimizu E, Nogami S, Suzuki K, Miura Y, Sentsui H.

J Vet Med Sci. 2009 Aug;71(8):1059-61.

28.

Minimally invasive magnetic resonance imaging-guided stereotactic radiofrequency thermocoagulation for epileptogenic hypothalamic hamartomas.

Kameyama S, Murakami H, Masuda H, Sugiyama I.

Neurosurgery. 2009 Sep;65(3):438-49; discussion 449. doi: 10.1227/01.NEU.0000348292.39252.B5.

PMID:
19687687
29.

Effect of hybridized liposome by novel modification with some polyethyleneglycol-lipids.

Sugiyama I, Sonobe T, Sadzuka Y.

Int J Pharm. 2009 May 8;372(1-2):177-83. doi: 10.1016/j.ijpharm.2009.01.010. Epub 2009 Jan 20.

PMID:
19429278
30.

Phototoxicity of coproporphyrin as a novel photodynamic therapy was enhanced by liposomalization.

Sadzuka Y, Iwasaki F, Sugiyama I, Horiuchi K, Hirano T, Ozawa H, Kanayama N, Oku N.

Toxicol Lett. 2008 Nov 10;182(1-3):110-4. doi: 10.1016/j.toxlet.2008.09.002. Epub 2008 Sep 12.

PMID:
18835340
31.

Effect of cathepsin K inhibitors on bone resorption.

Teno N, Masuya K, Ehara T, Kosaka T, Miyake T, Irie O, Hitomi Y, Matsuura N, Umemura I, Iwasaki G, Fukaya H, Toriyama K, Uchiyama N, Nonomura K, Sugiyama I, Kometani M.

J Med Chem. 2008 Sep 11;51(17):5459-62. doi: 10.1021/jm800626a. Epub 2008 Aug 16.

PMID:
18707091
32.

Study on liposomalization of zinc-coproporphyrin I as a novel drug in photodynamic therapy.

Sadzuka Y, Iwasaki F, Sugiyama I, Horiuchi K, Hirano T, Ozawa H, Kanayama N, Sonobe T.

Int J Pharm. 2007 Jun 29;338(1-2):306-9. Epub 2007 Feb 9.

PMID:
17349754
33.

Characterization of novel mixed polyethyleneglycol modified liposomes.

Sugiyama I, Sadzuka Y.

Biol Pharm Bull. 2007 Jan;30(1):208-11.

34.

Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.

Sadzuka Y, Sugiyama I, Tsuruda T, Sonobe T.

Int J Pharm. 2006 Apr 7;312(1-2):83-9. Epub 2006 Feb 2.

PMID:
16457972
35.

The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.

Sadzuka Y, Tokutomi K, Iwasaki F, Sugiyama I, Hirano T, Konno H, Oku N, Sonobe T.

Cancer Lett. 2006 Sep 8;241(1):42-8. Epub 2005 Nov 21.

PMID:
16303246
36.

[Case of prosthodontic treatment by overdenture with magnetic and bar attachments].

Sugiyama I.

Nihon Hotetsu Shika Gakkai Zasshi. 2005 Feb;49(1):93-6. Japanese.

PMID:
15838156
37.

Therapeutic efficacy of sustained drug release from chitosan gel on local inflammation.

Kofuji K, Akamine H, Qian CJ, Watanabe K, Togan Y, Nishimura M, Sugiyama I, Murata Y, Kawashima S.

Int J Pharm. 2004 Mar 19;272(1-2):65-78.

PMID:
15019070
38.

Functional roles of the tissue inhibitor of metalloproteinase 3 (TIMP-3) during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells.

Suzuki H, Nezaki Y, Kuno E, Sugiyama I, Mizutani A, Tsukagoshi N.

Biosci Biotechnol Biochem. 2003 Aug;67(8):1737-43.

39.

Ultrastructural analysis of the paranodal junction of myelinated fibers in 31-month-old-rats.

Sugiyama I, Tanaka K, Akita M, Yoshida K, Kawase T, Asou H.

J Neurosci Res. 2002 Nov 1;70(3):309-17.

PMID:
12391590
40.

Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells.

Mizutani A, Sugiyama I, Kuno E, Matsunaga S, Tsukagoshi N.

J Bone Miner Res. 2001 Nov;16(11):2043-9.

41.

Fyn tyrosine kinase participates in the compact myelin sheath formation in the central nervous system.

Seiwa C, Sugiyama I, Yagi T, Iguchi T, Asou H.

Neurosci Res. 2000 May;37(1):21-31.

PMID:
10802341
42.

[Development of "assessment guideline of family power for healthy life"].

Fukushima M, Shimanouchi S, Kamei T, Takagai E, Hoshino Y, Sugiyama I.

Nihon Kango Kagakkaishi. 1997 Dec;17(4):29-36. Japanese.

PMID:
10426073
43.

Suppression of glial tumor growth by expression of glial fibrillary acidic protein.

Toda M, Miura M, Asou H, Sugiyama I, Kawase T, Uyemura K.

Neurochem Res. 1999 Feb;24(2):339-43.

PMID:
9972884
44.

Studies on orally active cephalosporins. II. Synthesis and structure-activity relations of new [(E) or (Z) 3-substituted carbamoyloxy]-1-propenyl cephalosporins.

Negi S, Sasho M, Yamanaka M, Sugiyama I, Komatsu Y, Tsuruoka A, Kamada A, Tsukada I, Hiruma R, Katsu K, et al.

J Antibiot (Tokyo). 1994 Dec;47(12):1526-40.

45.

Studies on orally active cephalosporins. I. Synthesis and structure-activity relationships of new 3-substituted carbamoyloxymethyl cephalosporins.

Negi S, Yamanaka M, Sugiyama I, Komatsu Y, Sasho M, Tsuruoka A, Kamada A, Tsukada I, Hiruma R, Katsu K, et al.

J Antibiot (Tokyo). 1994 Dec;47(12):1507-25.

46.

Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin.

Watanabe N, Sugiyama I.

J Antibiot (Tokyo). 1992 Sep;45(9):1526-32.

47.

Application of a shape memory alloy to hand splinting.

Takami M, Fukui K, Saitou S, Sugiyama I, Terayama K.

Prosthet Orthot Int. 1992 Apr;16(1):57-63.

PMID:
1584645
48.
49.

[Focal point in recruiting family involvement and methods of assistance--case studies on health problem-related family crises and their solutions].

Ito M, Sugiyama I, Shimauchi S, Hoshino Y.

Hokenfu Zasshi. 1987 Mar;43(3):223-46. Japanese. No abstract available.

PMID:
2953917

Supplemental Content

Loading ...
Support Center